ストックスクリーナーアプリを入手
138.37
1.40%
-1.96
前日終値:
$140.33
開ける：
$140.6
24時間の取引高:
1.09M
Relative Volume:
0.74
時価総額：
$20.25B
収益：
$9.61B
当期純損益:
$1.62B
株価収益率:
12.50
EPS:
11.07
ネットキャッシュフロー:
$1.77B
1週間 パフォーマンス:
-1.80%
1か月 パフォーマンス:
-1.08%
6か月 パフォーマンス:
-28.92%
1年 パフォーマンス:
-35.83%
1日の値動き範囲:
$138.20
$141.25
1週間の範囲:
$138.20
$144.15
52週間の値動き範囲:
$128.51
$238.00
Biogen Inc Stock (BIIB) Company Profile
BIIB を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BIIB
Biogen Inc
|
138.37 | 20.25B | 9.61B | 1.62B | 1.77B | 11.07 |
|
LLY
Lilly Eli Co
|
822.51 | 738.75B | 45.04B | 10.59B | 414.30M | 11.71 |
|
ABBV
Abbvie Inc
|
205.29 | 363.15B | 56.33B | 4.28B | 17.83B | 2.40 |
|
JNJ
Johnson Johnson
|
163.71 | 344.63B | 88.82B | 14.07B | 18.06B | 5.79 |
|
NVO
Novo Nordisk Adr
|
69.30 | 311.44B | 42.09B | 14.65B | 10.11B | 3.2833 |
|
MRK
Merck Co Inc
|
89.23 | 225.40B | 64.17B | 17.12B | 18.10B | 6.73 |
Biogen Inc Stock (BIIB) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-02-11 | 開始されました | Bernstein | Mkt Perform |
| 2025-01-02 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2024-12-20 | ダウングレード | BMO Capital Markets | Outperform → Market Perform |
| 2024-12-16 | ダウングレード | Stifel | Buy → Hold |
| 2024-12-10 | 再開されました | BofA Securities | Neutral |
| 2024-12-09 | ダウングレード | Jefferies | Buy → Hold |
| 2024-11-18 | ダウングレード | Needham | Buy → Hold |
| 2024-11-15 | 開始されました | Wolfe Research | Peer Perform |
| 2024-11-14 | 開始されました | Citigroup | Neutral |
| 2024-10-31 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2024-10-10 | 再開されました | Raymond James | Mkt Perform |
| 2024-02-14 | 繰り返されました | Needham | Buy |
| 2024-02-14 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2024-01-24 | ダウングレード | UBS | Buy → Neutral |
| 2023-12-20 | 再開されました | Cantor Fitzgerald | Overweight |
| 2023-12-07 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2023-09-06 | 開始されました | HSBC Securities | Buy |
| 2023-07-27 | 開始されました | Scotiabank | Sector Outperform |
| 2023-07-24 | 繰り返されました | UBS | Buy |
| 2023-05-01 | アップグレード | Guggenheim | Neutral → Buy |
| 2023-04-17 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2022-10-26 | アップグレード | Goldman | Neutral → Buy |
| 2022-10-13 | アップグレード | Stifel | Hold → Buy |
| 2022-10-07 | アップグレード | Argus | Hold → Buy |
| 2022-09-28 | アップグレード | BMO Capital Markets | Market Perform → Outperform |
| 2022-09-28 | アップグレード | Mizuho | Neutral → Buy |
| 2022-09-28 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2022-04-18 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2022-03-08 | ダウングレード | Stifel | Buy → Hold |
| 2022-03-03 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-02-04 | ダウングレード | BMO Capital Markets | Outperform → Market Perform |
| 2022-02-04 | 繰り返されました | Barclays | Equal Weight |
| 2022-02-04 | 繰り返されました | BofA Securities | Neutral |
| 2022-02-04 | 繰り返されました | Cowen | Outperform |
| 2022-02-04 | 繰り返されました | Morgan Stanley | Overweight |
| 2022-02-04 | 繰り返されました | Needham | Buy |
| 2022-02-04 | 繰り返されました | Oppenheimer | Outperform |
| 2022-02-04 | 繰り返されました | RBC Capital Mkts | Sector Perform |
| 2022-02-04 | 繰り返されました | Robert W. Baird | Neutral |
| 2022-02-04 | 繰り返されました | Wedbush | Neutral |
| 2022-02-04 | 繰り返されました | Wells Fargo | Equal Weight |
| 2022-02-04 | 繰り返されました | Wolfe Research | Peer Perform |
| 2022-01-13 | ダウングレード | Guggenheim | Buy → Neutral |
| 2022-01-12 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2021-12-10 | 再開されました | Raymond James | Mkt Perform |
| 2021-12-09 | 再開されました | Wells Fargo | Equal Weight |
| 2021-12-06 | 開始されました | Goldman | Neutral |
| 2021-11-19 | 開始されました | BMO Capital Markets | Outperform |
| 2021-09-23 | 開始されました | Needham | Buy |
| 2021-06-18 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2021-06-14 | 繰り返されました | Truist | Buy |
| 2021-06-11 | アップグレード | Bernstein | Mkt Perform → Outperform |
| 2021-06-10 | アップグレード | UBS | Neutral → Buy |
| 2021-06-08 | アップグレード | Atlantic Equities | Underweight → Neutral |
| 2021-06-08 | 繰り返されました | Barclays | Equal Weight |
| 2021-06-08 | アップグレード | Citigroup | Sell → Neutral |
| 2021-06-08 | 繰り返されました | H.C. Wainwright | Buy |
| 2021-06-08 | 繰り返されました | Jefferies | Buy |
| 2021-06-08 | 繰り返されました | Morgan Stanley | Overweight |
| 2021-06-08 | 繰り返されました | RBC Capital Mkts | Sector Perform |
| 2021-06-08 | アップグレード | Robert W. Baird | Underperform → Neutral |
| 2021-06-08 | 繰り返されました | Stifel | Buy |
| 2021-06-08 | アップグレード | William Blair | Mkt Perform → Outperform |
| 2021-06-07 | アップグレード | BofA Securities | Underperform → Neutral |
| 2021-06-07 | アップグレード | Cowen | Market Perform → Outperform |
| 2021-06-07 | アップグレード | Raymond James | Underperform → Mkt Perform |
| 2021-02-05 | ダウングレード | DZ Bank | Buy → Hold |
| 2021-01-29 | アップグレード | Stifel | Hold → Buy |
| 2020-11-10 | アップグレード | DZ Bank | Hold → Buy |
| 2020-11-09 | ダウングレード | Atlantic Equities | Neutral → Underweight |
| 2020-11-09 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2020-11-09 | ダウングレード | Cowen | Outperform → Market Perform |
| 2020-11-09 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-11-04 | アップグレード | BofA Securities | Underperform → Neutral |
| 2020-11-04 | アップグレード | Jefferies | Hold → Buy |
| 2020-11-04 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2020-10-28 | 開始されました | UBS | Neutral |
| 2020-07-27 | アップグレード | Morgan Stanley | Underweight → Overweight |
| 2020-06-22 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2020-06-22 | 繰り返されました | RBC Capital Mkts | Sector Perform |
| 2020-06-09 | ダウングレード | Bernstein | Outperform → Mkt Perform |
| 2020-04-23 | ダウングレード | Citigroup | Neutral → Sell |
| 2020-04-23 | ダウングレード | Raymond James | Mkt Perform → Underperform |
| 2020-03-31 | 開始されました | Wolfe Research | Peer Perform |
| 2020-02-27 | 開始されました | Barclays | Overweight |
| 2020-01-27 | アップグレード | Canaccord Genuity | Hold → Buy |
| 2019-12-13 | アップグレード | Credit Suisse | Underperform → Neutral |
| 2019-12-02 | ダウングレード | Robert W. Baird | Neutral → Underperform |
すべてを表示
Biogen Inc (BIIB) 最新ニュース
Eli Lilly Alzheimer’s Drug Kisunla Fails to Get EU Backing - Mint
European Drug Regulator Gives Thumbs Down To Eli Lilly's Alzheimer's Drug, Analyst Says It Is Incremental Win For Biogen - Benzinga
Lilly hits same Alzheimer’s roadblock in Europe as Eisai, Biogen - BioPharma Dive
Trend Tracker for (BIIB) - Stock Traders Daily
Thrivent Financial for Lutherans Decreases Position in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Biogen Inc. (NASDAQ:BIIB) Shares Acquired by Teacher Retirement System of Texas - MarketBeat
HighTower Advisors LLC Has $1.28 Million Holdings in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Natixis Advisors LLC Reduces Stock Holdings in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Hillsdale Investment Management Inc. Buys Shares of 4,610 Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Biogen Inc. (NASDAQ:BIIB) Stock Holdings Trimmed by Northwest & Ethical Investments L.P. - MarketBeat
BIIB SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman LLC Reminds Biogen Inc. Investors to Join the Class Action Lawsuit! - ACCESS Newswire
Biogen: Balancing Risks And Opportunities - Seeking Alpha
Mizuho Securities USA LLC Acquires 4,366 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Biogen Inc. (NASDAQ:BIIB) Stake Trimmed by Virtu Financial LLC - MarketBeat
Biogen plans new headquarters at Kendall Common - MSN
Beyond GLP-1 Drugs: This Opportunity at Eli Lilly Could Surprise Everyone in 2025 - The Motley Fool
Lilly adds Alzheimer's to online offerings - Marketscreener.com
6,175 Shares in Biogen Inc. (NASDAQ:BIIB) Acquired by Crowley Wealth Management Inc. - MarketBeat
Vanguard Group Inc. Raises Stock Position in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Biogen to Move Global Headquarters to Kendall Commons in 2028 - Harvard Crimson
Biogen Inc. (NASDAQ:BIIB) Shares Purchased by Prudential Financial Inc. - MarketBeat
1,874 Shares in Biogen Inc. (NASDAQ:BIIB) Purchased by Vinva Investment Management Ltd - MarketBeat
BIOGEN TO REPORT FIRST QUARTER 2025 FINANCIAL RESULTS MAY 1, 2025 - Biogen | Investor Relations
Roche Voids Biogen's Protein Production Patent At EPO - Law360
Biogen Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before July 22, 2024 to Discuss Your RightsBIIB - ACCESS Newswire
Biogen Announces Plans for New Global Headquarters and Innovation Hub in Kendall Square - Boston Real Estate Times
Cassava Sciences shuts down Alzheimer's programshares plummet - Marketscreener.com
KLP Kapitalforvaltning AS Acquires Shares of 92,377 Biogen Inc. (NASDAQ:BIIB) - MarketBeat
News | Blackstone’s BioMed adds biotech hub in Boston area with added demand - CoStar Group
7 Stocks Still Trading Below COVID Lows 5 Years Later - MSN
Biogen to Relocate Headquarters to New Development by MIT and BioMed - Connect CRE
Biogen to consolidate operations at new global headquarters in Cambridge - FirstWord Pharma
Biogen plots new global headquarters in Kendall Square - BioPharma Dive
Biogen Relocating to MIT Development in Cambridge - Banker & Tradesman
Biogen Signs Lease for New Global HQ in Cambridge, Massachusetts -March 24, 2025 at 09:37 am EDT - Marketscreener.com
Biogen Plans New Global Headquarters in Cambridge, Massachusetts -March 24, 2025 at 08:18 am EDT - Marketscreener.com
Biogen to establish new HQ in Cambridge by 2028 - Investing.com
Biogen Plans For State-of-the-Art Global Headquarters At Kendall Common, Set To Open In 2028 - Nasdaq
Biogen Announces Plans For New Global Headquarters And Innovation Hub In Kendall Square - Marketscreener.com
Biogen to move HQ to new tower in MIT Kendall development - The Business Journals
Biogen Inc. (NASDAQ:BIIB) Shares Sold by Commonwealth Equity Services LLC - MarketBeat
Biogen to move its Cambridge headquarters in 2028 - The Boston Globe
Harvest Fund Management Co. Ltd Increases Stake in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Generali Investments Management Co LLC Makes New $410,000 Investment in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Intech Investment Management LLC Makes New Investment in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Investors in Biogen Inc. Should Contact Levi & Korsinsky Before July 22, 2024 to Discuss Your RightsBIIB - ACCESS Newswire
OVERSEA CHINESE BANKING Corp Ltd Buys 28,524 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Generali Asset Management SPA SGR Takes $2.48 Million Position in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Are Biogen Inc.'s (NASDAQ:BIIB) Mixed Financials The Reason For Its Gloomy Performance on The Stock Market? - Simply Wall St
Sector Gamma AS Sells 6,166 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Biogen Inc. (NASDAQ:BIIB) Shares Sold by Tocqueville Asset Management L.P. - MarketBeat
Biogen Inc (BIIB) 財務データ
収益
当期純利益
現金流量
EPS
1.66%
大文字化:
|
ボリューム (24 時間):